{
  "ticker": "IDXX",
  "last_updated": "2025-04-19T07:04:25.897197",
  "retention_years": 3,
  "count": 43,
  "transactions": [
    {
      "id": 14372,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "POLEWACZYK JAMES F",
      "reporting_owner_cik": "0001389046",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "755",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "11466.2345"
    },
    {
      "id": 14370,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Vandebroek Sophie V.",
      "reporting_owner_cik": "0001442078",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-05",
      "transaction_shares": "1404",
      "transaction_price": "245.79",
      "transaction_type": "M",
      "shares_after_transaction": "2620"
    },
    {
      "id": 14365,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-29",
      "transaction_shares": "550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "81496.5926"
    },
    {
      "id": 4523,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "82046.5926"
    },
    {
      "id": 14364,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "82046.5926"
    },
    {
      "id": 4533,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Underberg Sharon E.",
      "reporting_owner_cik": "0001630353",
      "reporting_owner_position": "EVP, GC & Corporate Secretary",
      "transaction_date": "2024-02-16",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "5594.9449"
    },
    {
      "id": 14377,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Underberg Sharon E.",
      "reporting_owner_cik": "0001630353",
      "reporting_owner_position": "EVP, GC & Corporate Secretary",
      "transaction_date": "2024-02-16",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "5594.9449"
    },
    {
      "id": 4527,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-15",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "30834.5926"
    },
    {
      "id": 14369,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-15",
      "transaction_shares": "483",
      "transaction_price": "206.94",
      "transaction_type": "M",
      "shares_after_transaction": "30834.5926"
    },
    {
      "id": 4520,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Smith Martin Alexander",
      "reporting_owner_cik": "0001621358",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "148",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "393.95"
    },
    {
      "id": 4522,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "FENNELL GEORGE",
      "reporting_owner_cik": "0001521861",
      "reporting_owner_position": "SVP, Chief Revenue Officer",
      "transaction_date": "2024-02-14",
      "transaction_shares": "108",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6820"
    },
    {
      "id": 4524,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-14",
      "transaction_shares": "435",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "79681.5926"
    },
    {
      "id": 4525,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-14",
      "transaction_shares": "435",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "30152.5926"
    },
    {
      "id": 4530,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Lane Michael",
      "reporting_owner_cik": "0001740689",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "181",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5968.2345"
    },
    {
      "id": 4531,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "POLEWACZYK JAMES F",
      "reporting_owner_cik": "0001389046",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "126",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10189.2345"
    },
    {
      "id": 4534,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Johnson Michael Perkins",
      "reporting_owner_cik": "0001917747",
      "reporting_owner_position": "EVP and CHRO",
      "transaction_date": "2024-02-14",
      "transaction_shares": "176",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "243.3419"
    },
    {
      "id": 4535,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Hunt Nimrata",
      "reporting_owner_cik": "0001800619",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "126",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11193.2345"
    },
    {
      "id": 4537,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Underberg Sharon E.",
      "reporting_owner_cik": "0001630353",
      "reporting_owner_position": "EVP, GC & Corporate Secretary",
      "transaction_date": "2024-02-14",
      "transaction_shares": "483",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4764.9449"
    },
    {
      "id": 4538,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Erickson Michael G",
      "reporting_owner_cik": "0002005385",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "108",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10447.3617"
    },
    {
      "id": 4539,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Schreck Michael",
      "reporting_owner_cik": "0002004990",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "80",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "615"
    },
    {
      "id": 14361,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Smith Martin Alexander",
      "reporting_owner_cik": "0001621358",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "148",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "393.95"
    },
    {
      "id": 14363,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "FENNELL GEORGE",
      "reporting_owner_cik": "0001521861",
      "reporting_owner_position": "SVP, Chief Revenue Officer",
      "transaction_date": "2024-02-14",
      "transaction_shares": "108",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6820"
    },
    {
      "id": 14366,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-14",
      "transaction_shares": "435",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "79681.5926"
    },
    {
      "id": 14367,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-14",
      "transaction_shares": "435",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "30152.5926"
    },
    {
      "id": 14374,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Lane Michael",
      "reporting_owner_cik": "0001740689",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "181",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5968.2345"
    },
    {
      "id": 14375,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "POLEWACZYK JAMES F",
      "reporting_owner_cik": "0001389046",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "126",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10189.2345"
    },
    {
      "id": 14378,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Johnson Michael Perkins",
      "reporting_owner_cik": "0001917747",
      "reporting_owner_position": "EVP and CHRO",
      "transaction_date": "2024-02-14",
      "transaction_shares": "176",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "243.3419"
    },
    {
      "id": 14379,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Hunt Nimrata",
      "reporting_owner_cik": "0001800619",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "126",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11193.2345"
    },
    {
      "id": 14381,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Underberg Sharon E.",
      "reporting_owner_cik": "0001630353",
      "reporting_owner_position": "EVP, GC & Corporate Secretary",
      "transaction_date": "2024-02-14",
      "transaction_shares": "483",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4764.9449"
    },
    {
      "id": 14382,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Erickson Michael G",
      "reporting_owner_cik": "0002005385",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "108",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10447.3617"
    },
    {
      "id": 14383,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "Schreck Michael",
      "reporting_owner_cik": "0002004990",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-02-14",
      "transaction_shares": "80",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "615"
    },
    {
      "id": 4526,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "AYERS JONATHAN W",
      "reporting_owner_cik": "0001184149",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-09",
      "transaction_shares": "5350",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "265394"
    },
    {
      "id": 14368,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "AYERS JONATHAN W",
      "reporting_owner_cik": "0001184149",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-09",
      "transaction_shares": "5350",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "265394"
    },
    {
      "id": 4521,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "FENNELL GEORGE",
      "reporting_owner_cik": "0001521861",
      "reporting_owner_position": "SVP, Chief Revenue Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1612",
      "transaction_price": "62",
      "transaction_type": "M",
      "shares_after_transaction": "6712"
    },
    {
      "id": 14362,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "FENNELL GEORGE",
      "reporting_owner_cik": "0001521861",
      "reporting_owner_position": "SVP, Chief Revenue Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1612",
      "transaction_price": "62",
      "transaction_type": "M",
      "shares_after_transaction": "6712"
    },
    {
      "id": 4529,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "AYERS JONATHAN W",
      "reporting_owner_cik": "0001184149",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "271594"
    },
    {
      "id": 4532,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "12000",
      "transaction_price": "67.85",
      "transaction_type": "M",
      "shares_after_transaction": "91246.5926"
    },
    {
      "id": 4536,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "23326",
      "transaction_price": "141.60",
      "transaction_type": "M",
      "shares_after_transaction": "53043.5926"
    },
    {
      "id": 14373,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "AYERS JONATHAN W",
      "reporting_owner_cik": "0001184149",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "271594"
    },
    {
      "id": 14376,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MAZELSKY JONATHAN JAY",
      "reporting_owner_cik": "0001556270",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "12000",
      "transaction_price": "67.85",
      "transaction_type": "M",
      "shares_after_transaction": "91246.5926"
    },
    {
      "id": 14380,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "MCKEON BRIAN P",
      "reporting_owner_cik": "0001219445",
      "reporting_owner_position": "EVP, CFO and Treasurer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "23326",
      "transaction_price": "141.60",
      "transaction_type": "M",
      "shares_after_transaction": "53043.5926"
    },
    {
      "id": 4528,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "JUNIUS DANIEL M",
      "reporting_owner_cik": "0001094159",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "14",
      "transaction_price": "521.03",
      "transaction_type": "A",
      "shares_after_transaction": "3042"
    },
    {
      "id": 14371,
      "issuer_name": "IDEXX LABORATORIES INC /DE",
      "reporting_owner": "JUNIUS DANIEL M",
      "reporting_owner_cik": "0001094159",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "14",
      "transaction_price": "521.03",
      "transaction_type": "A",
      "shares_after_transaction": "3042"
    }
  ]
}